Physician profile
Mary E Hartsell
NPI 1760573612
$3,582.12
in general payments reported to CMS, 2019-2025
20 companies · $692 in 2025
The $692 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $1,287 · 2023: $489 · 2024: $780 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.40 |
| Education | $101.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,983.25 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $238.33 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $172.00 | 2021-2024 | Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $146.11 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $141.12 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $118.52 | 2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $97.81 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $97.50 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $87.55 | 2021-2022 | |
| Alkermes, INC. | $84.13 | 2021-2022 | |
| Corium, LLC | $82.14 | 2022 | |
| Bausch Health US, LLC | $71.31 | 2022-2025 | Aplenzin, Wellbutrin |
| Sunovion Pharmaceuticals INC. | $56.20 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $49.57 | 2022 | |
| Lundbeck LLC | $46.05 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.63 | 2022 | |
| Ironshore Pharmaceuticals INC. | $24.88 | 2022 | |
| Adlon Therapeutics L.P. | $17.62 | 2021 | |
| Almatica Pharma LLC | $14.86 | 2022 | |
| Tris Pharma INC | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hartsell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.